IP Library Granted Patent US 11,951,202
Granted Patent B2
US 11,951,202 · App. 17/370,074 · Granted Apr 9, 2024

Compounds and compositions for use

Inventor: Mike Finnen (Edinburgh, GB)
Assignee: DR WELLER LIMITED
A61K8/63A61K8/19A61K8/36A61K8/361A61K8/447A61K8/46A61K8/4986A61K8/64A61Q17/04A61Q19/00A61K2800/592
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,951,202
App. No.
17/370,074
Granted
Apr 9, 2024
Kind
B2
Abstract

The present disclosure provides compounds and compositions which may be used to augment, supplement and/or replace the products of certain UV sensitive/dependent processes. In particular, the disclosure provides sunscreen compositions which avoid problems associated with prior art sunscreen compositions which inhibit the natural progression of certain in vivo sunlight/UV dependent processes including processes which result in Nitric Oxide/Vitamin D production in the skin.

Claims (56)

1. A method of treating diseases associated with reduced, impaired or inhibited nitric oxide (NO) and/or vitamin D production, said method comprising administering to a subject in need thereof a composition comprising:

(i) a thiol compound selected from the group consisting of: glutathione, cysteine, homocysteine, cysteamine and thiolactate, and/or a disulfide selected from the group consisting of: dithioglycolate; lipoic acid (oxidised) and cystine; and

(ii) a NO-precursor compound selected from the group consisting of: nitrite-containing compounds; nitrate-containing compounds; and nitro-containing organic compounds.

2. The method of claim 1 , wherein the composition further comprises:

(iii) 7-dehydrocholesterol.

3. The method of claim 1 , wherein the NO-precursor compound is selected from the group consisting of:

metal nitrites;

sodium nitrite (NaNO 2 );

potassium nitrite;

dinitrosyl-iron complexes;

iron sulfur compounds;

sodium nitrate;

potassium nitrate;

carboxylic acid comprising a nitro (—NO 2 ) group;

nitropropionic acid;

nitrooleate;

3-nitropropionic acid;

9-nitrooleate; and

10-nitrool eate.

4. The method of claim 1 , wherein the subject is a subject exposed or to be exposed to the sun and requiring the use of a sunscreen composition.

5. The method of claim 1 , wherein the composition is administered to, applied to or used by a subject:

(i) to be exposed to the sun; or

(ii) a subject susceptible, predisposed to or at risk of developing a disease or condition associated with reduced NO and/or vitamin D(3) production.

6. The method of claim 1 , wherein when the NO-precursor compound is a metal nitrate, the metal nitrate is selected from sodium nitrate and potassium nitrate.

7. A method of augmenting or stimulating nitric oxide (NO) production in a subject in need thereof, said subject wearing or using a sunscreen composition, said method comprising using, applying or administering a sunscreen composition comprising:

(i) a thiol compound selected from the group consisting of: glutathione, cysteine, homocysteine, cysteamine and thiolactate, and/or a disulfide selected from the group consisting of: dithioglycolate; lipoic acid (oxidised) and cystine; and

(ii) a NO-precursor compound selected from the group consisting of: nitrite-containing compounds; nitrate-containing compounds; and nitro-containing organic compounds.

8. The method of claim 7 , wherein the composition further comprises:

(iii) 7-dehydrocholesterol and the method further comprises augmenting or stimulating vitamin D3 production in a subject wearing or using a sunscreen composition.

9. The method of claim 7 , wherein the NO-precursor compound is selected from the group consisting of:

metal nitrites;

sodium nitrite (NaNO 2 );

potassium nitrite;

dinitrosyl-iron complexes;

iron sulfur compounds;

sodium nitrate;

potassium nitrate;

carboxylic acid comprising a nitro (—NO 2 ) group;

nitropropionic acid;

nitrooleate;

3-nitropropionic acid;

9-nitrooleate; and

10-nitrooleate.

10. The method of claim 7 , wherein the subject is a subject exposed or to be exposed to the sun and requiring the use of a sunscreen composition.

11. The method of claim 7 , wherein the composition is administered to, applied to or used by a subject:

(i) to be exposed to the sun; or

(ii) a subject susceptible, predisposed to or at risk of developing a disease or condition associated with reduced NO and/or vitamin D(3) production.

12. The method of claim 7 , wherein when the NO-precursor compound is a metal nitrate, the metal nitrate is selected from sodium nitrate and potassium nitrate.

13. A method of providing a sunscreen composition which:

(i) does not substantially inhibit NO and/or vitamin D production in a subject in need thereof; and/or

(ii) which facilitates, enhances, induces and/or stimulates a level of vitamin D and/or NO production in a subject in need thereof;

said method comprising supplementing a sunscreen composition with:

(i) (a) a thiol compound selected from the group consisting of: glutathione, cysteine, homocysteine, cysteamine and thiolactate, and/or a disulfide selected from the group consisting of: dithioglycolate; lipoic acid (oxidised) and cystine; and

(b) a NO-precursor compound selected from the group consisting of: nitrite-containing compounds; nitrate-containing compounds; and nitro-containing organic compounds; and optionally

(ii) 7-dehydrocholesterol.

14. The method of claim 13 , wherein when the NO-precursor compound is a metal nitrate, the metal nitrate is selected from sodium nitrate and potassium nitrate.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2025
From: FINNEN, MIKE
To: RELAXSOL LIMITED
Reel/Frame 071941/0036 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2025
From: DR. WELLER LIMITED
To: ELLIPSIS BRANDS LIMITED
Reel/Frame 071941/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2025
From: ELLIPSIS BRANDS LIMITED
To: AMPERSAND HOLDINGS LIMITED
Reel/Frame 071941/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2025
From: RELAXSOL LIMITED
To: WELLER, RICHARD, DR.
Reel/Frame 072337/0057 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2025
From: WELLER, RICHARD, DR.
To: DR WELLER LIMITED
Reel/Frame 072391/0330 →
Priority Claims (1)
GB 1614961 · Sep 2, 2016 · national
Continuity (2)
Continuation 16329945
Related Publication 20210330567A1 · Oct 28, 2021
Cited By (1)
US 1,078,998